Last 12 months
Inside the activity.
5 purchase rows · 15 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 5 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 11 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 4 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 21, 2023 Filed Jul 25, 2023 16:33 UTC |
Levisetti MatteoChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 82,500 | $0.00 Strike: $4.20 | $0.00 |
DisclosureSEC source: 0001209191-23-043278 · doc4.xml · derivative · entry 1 Levisetti Matteo · CIK 0001962444 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,500 Underlying: Common Stock · 82,500 shares Expires 2033-07-20 F1 · derivative.exercise_date: This stock option grant becomes exercisable in twenty four equal monthly installments beginning on August 21, 2023. Read SEC document |
| July 21, 2023 Filed Jul 25, 2023 16:25 UTC |
Suri AnishPRESIDENT AND CSO
|
GrantStock Option (right to buy) · Derivative | 124,125 | $0.00 Strike: $4.20 | $0.00 |
DisclosureSEC source: 0001209191-23-043273 · doc4.xml · derivative · entry 1 Suri Anish · CIK 0001739130 · PRESIDENT AND CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,125 Underlying: Common Stock · 124,125 shares Expires 2033-07-20 F1 · derivative.exercise_date: This stock option grant becomes exercisable in twenty four equal monthly installments beginning on August 21, 2023. Read SEC document |
| July 21, 2023 Filed Jul 25, 2023 16:31 UTC |
Millar Kerri-AnnCHIEF FINANCIAL OFFICER
|
GrantStock Option (right to buy) · Derivative | 113,000 | $0.00 Strike: $4.20 | $0.00 |
DisclosureSEC source: 0001209191-23-043277 · doc4.xml · derivative · entry 1 Millar Kerri-Ann · CIK 0001739126 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,000 Underlying: Common Stock · 113,000 shares Expires 2033-07-20 F1 · derivative.exercise_date: This stock option grant becomes exercisable in twenty four equal monthly installments beginning on August 21, 2023. Read SEC document |
| April 19, 2023 Filed Apr 21, 2023 20:15 UTC |
Garzone PamelaDirector
|
GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $3.46 | $0.00 |
DisclosureSEC source: 0001209191-23-025142 · doc4.xml · derivative · entry 1 Garzone Pamela · CIK 0001974756 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2033-04-18 F1 · derivative.exercise_date: This stock option grant becomes exercisable over three years with one-third vesting on the one-year anniversary of the grant date and the balance vesting in eight equal quarterly installments. Read SEC document |
| April 11, 2023 Filed Apr 13, 2023 20:42 UTC |
Verheyen PatrickDirector
|
GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $3.11 | $0.00 |
DisclosureSEC source: 0001209191-23-024220 · doc4.xml · derivative · entry 1 Verheyen Patrick · CIK 0001972605 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2033-04-10 F1 · derivative.exercise_date: This stock option grant becomes exercisable over three years with one-third vesting on the one-year anniversary of the grant date and the balance vesting in eight equal quarterly installments. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 16:05 UTC |
Kiener Peter ADirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 9,682 | $0.00 Strike: $2.86 | $0.00 |
DisclosureSEC source: 0001209191-23-021201 · doc4.xml · derivative · entry 3 Kiener Peter A · CIK 0001328146 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,062 Underlying: Common Stock · 9,682 shares Expires 2023-03-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This Stock Option became exercisable in five equal annual installments beginning March 23, 2017 and is fully vested. This stock option expired on March 23, 2023. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 16:05 UTC |
Kiener Peter ADirector
|
SaleCommon Stock | 9,325 | $3.28 | $30,586.00 |
DisclosureSEC source: 0001209191-23-021201 · doc4.xml · nonDerivative · entry 2 Kiener Peter A · CIK 0001328146 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 357 F1 · kind: Sale to cover exercise price of cashless exercise of stock option. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.20 to $3.31, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 16:05 UTC |
Kiener Peter ADirector
|
Exercise / conversionCommon Stock | 9,682 | $2.86 | $27,690.52 |
DisclosureSEC source: 0001209191-23-021201 · doc4.xml · nonDerivative · entry 1 Kiener Peter A · CIK 0001328146 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,682 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 22:00 UTC |
Sandercock ColinSVP, GENERAL COUNSEL
|
GrantStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $3.21 | $0.00 |
DisclosureSEC source: 0001209191-23-011249 · doc4.xml · derivative · entry 1 Sandercock Colin · CIK 0001724870 · SVP, GENERAL COUNSEL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2033-02-15 F1 · derivative.exercise_date: This stock option becomes exercisable in eight equal semi-annual installments beginning on August 16, 2023. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 16:59 UTC |
PASSERI DANIEL RDirector · CHIEF EXECUTIVE OFFICER
|
GrantStock Option (right to buy) · Derivative | 324,000 | $0.00 Strike: $3.21 | $0.00 |
DisclosureSEC source: 0001209191-23-011247 · doc4.xml · derivative · entry 1 PASSERI DANIEL R · CIK 0001190121 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 324,000 Underlying: Common Stock · 324,000 shares Expires 2033-02-15 F1 · derivative.exercise_date: This stock option becomes exercisable in eight equal semi-annual installments beginning on August 16, 2023. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 17:03 UTC |
NASSHORN PATRICIAChief Business Officer
|
GrantStock Option (right to buy) · Derivative | 97,900 | $0.00 Strike: $3.21 | $0.00 |
DisclosureSEC source: 0001209191-23-011270 · doc4.xml · derivative · entry 1 NASSHORN PATRICIA · CIK 0001251374 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,900 Underlying: Common Stock · 97,900 shares Expires 2033-02-15 F1 · derivative.exercise_date: This stock option becomes exercisable in eight equal semi-annual installments beginning on August 16, 2023. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 22:01 UTC |
Suri AnishPRESIDENT AND CSO
|
GrantStock Option (right to buy) · Derivative | 125,500 | $0.00 Strike: $3.21 | $0.00 |
DisclosureSEC source: 0001209191-23-011255 · doc4.xml · derivative · entry 1 Suri Anish · CIK 0001739130 · PRESIDENT AND CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,500 Underlying: Common Stock · 125,500 shares Expires 2033-02-15 F1 · derivative.exercise_date: This stock option becomes exercisable in eight equal semi-annual installments beginning on August 16, 2023. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 21:58 UTC |
Millar Kerri-AnnCHIEF FINANCIAL OFFICER
|
GrantStock Option (right to buy) · Derivative | 124,000 | $0.00 Strike: $3.21 | $0.00 |
DisclosureSEC source: 0001209191-23-011245 · doc4.xml · derivative · entry 1 Millar Kerri-Ann · CIK 0001739126 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,000 Underlying: Common Stock · 124,000 shares Expires 2033-02-15 F1 · derivative.exercise_date: This stock option becomes exercisable in eight equal semi-annual installments beginning on August 16, 2023. Read SEC document |
| January 17, 2023 Filed Jan 19, 2023 21:02 UTC |
Levisetti MatteoChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 110,000 | $0.00 Strike: $3.36 | $0.00 |
DisclosureSEC source: 0001209191-23-003988 · doc4.xml · derivative · entry 1 Levisetti Matteo · CIK 0001962444 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,000 Underlying: Common Stock · 110,000 shares Expires 2033-01-16 F1 · derivative.exercise_date: This stock option grant becomes exercisable in eight equal semi-annual installments beginning on 7/17/2023 Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:08 UTC |
DRISCOLL FREDERICK WDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $2.66 | $0.00 |
DisclosureSEC source: 0001209191-23-001776 · doc4.xml · derivative · entry 1 DRISCOLL FREDERICK W · CIK 0001129890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2033-01-02 F1 · shares: Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy. F2 · derivative.exercise_date: This option was granted on January 3, 2023. The shares underlying the option are scheduled to vest in full on the anniversary date of the grant date. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:09 UTC |
HOWSON TAMAR DDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $2.66 | $0.00 |
DisclosureSEC source: 0001209191-23-001785 · doc4.xml · derivative · entry 1 HOWSON TAMAR D · CIK 0001202286 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2033-01-02 F1 · shares: Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy. F2 · derivative.exercise_date: This option was granted on January 3, 2023. The shares underlying the option are scheduled to vest in full on the anniversary date of the grant date. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 16:10 UTC |
Kiener Peter ADirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $2.66 | $0.00 |
DisclosureSEC source: 0001209191-23-001789 · doc4.xml · derivative · entry 1 Kiener Peter A · CIK 0001328146 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2033-01-02 F1 · shares: Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy. F2 · derivative.exercise_date: This option was granted on January 3, 2023. The shares underlying the option are scheduled to vest in full on the anniversary date of the grant date. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:11 UTC |
Morich FrankDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $2.66 | $0.00 |
DisclosureSEC source: 0001209191-23-001796 · doc4.xml · derivative · entry 1 Morich Frank · CIK 0001748615 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2033-01-02 F1 · shares: Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy. F2 · derivative.exercise_date: This option was granted on January 3, 2023. The shares underlying the option are scheduled to vest in full on the anniversary date of the grant date. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:08 UTC |
Fletcher Aaron G.L.Director
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $2.66 | $0.00 |
DisclosureSEC source: 0001209191-23-001780 · doc4.xml · derivative · entry 1 Fletcher Aaron G.L. · CIK 0001789490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2033-01-02 F1 · shares: Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy. F2 · derivative.exercise_date: This option was granted on January 3, 2023. The shares underlying the option are scheduled to vest in full on the anniversary date of the grant date. Read SEC document |
| August 22, 2022 Filed Aug 23, 2022 20:03 UTC |
Millar Kerri-AnnCHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 2,828 | $3.05 | $8,625.40 |
DisclosureSEC source: 0001209191-22-047161 · doc4.xml · nonDerivative · entry 2 Millar Kerri-Ann · CIK 0001739126 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,311 Read SEC document |
| August 21, 2022 Filed Aug 23, 2022 20:03 UTC |
Millar Kerri-AnnCHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 6,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-047161 · doc4.xml · derivative · entry 3 Millar Kerri-Ann · CIK 0001739126 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit award represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Represents a restricted stock unit award granted on August 21, 2020. The restricted stock units vest in three equal annual installments beginning on August 21, 2020. F3 · derivative.expiration_date: Represents a restricted stock unit award granted on August 21, 2020. The restricted stock units vest in three equal annual installments beginning on August 21, 2020. Read SEC document |
| August 21, 2022 Filed Aug 23, 2022 20:03 UTC |
Millar Kerri-AnnCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 6,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-047161 · doc4.xml · nonDerivative · entry 1 Millar Kerri-Ann · CIK 0001739126 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,139 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award F1 · price: Represents shares of common stock received upon vesting of a restricted stock unit award Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 16:01 UTC |
Gray CameronDirector
|
OtherWarrants · Derivative | 61,111 | $0.00 Strike: $2.70 | $0.00 |
DisclosureSEC source: 0001209191-22-037394 · doc4.xml · derivative · entry 3 Gray Cameron · CIK 0001590583 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 61,111 shares Expires 2022-06-15 Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 16:01 UTC |
Gray CameronDirector
|
Tax withholdingCommon Stock | 51,562 | $3.20 | $164,998.40 |
DisclosureSEC source: 0001209191-22-037394 · doc4.xml · nonDerivative · entry 2 Gray Cameron · CIK 0001590583 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 687,049 F1 · kind: On June 14, 2022, the reporting person exercised a warrant to purchase 61,111 shares of the Issuers common stock for $2.70 a share. The reporting person paid the exercise price on a cashless basis, resulting in the Issuer withholding of 51,562 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 9,549 shares. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 16:01 UTC |
Gray CameronDirector
|
OtherCommon Stock | 61,111 | $2.70 | $164,999.70 |
DisclosureSEC source: 0001209191-22-037394 · doc4.xml · nonDerivative · entry 1 Gray Cameron · CIK 0001590583 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 738,611 Read SEC document |
| May 27, 2022 Filed May 31, 2022 20:06 UTC |
Morich FrankDirector
|
PurchaseCommon Stock | 28,000 | $3.75 | $105,000.00 |
DisclosureSEC source: 0001209191-22-032800 · doc4.xml · nonDerivative · entry 1 Morich Frank · CIK 0001748615 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,000 Read SEC document |
| May 24, 2022 Filed May 25, 2022 13:09 UTC |
Fletcher Aaron G.L.Director
|
PurchaseCommon Stock | 55,000 | $3.34 | $183,700.00 |
DisclosureSEC source: 0001209191-22-031791 · doc4.xml · nonDerivative · entry 2 Fletcher Aaron G.L. · CIK 0001789490 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 940,000 F3 · shares: The reported shares were purchased in the open market in multiple transactions at prices ranging from $3.21 to $3.52. The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Cue Biopharma, Inc., any stockholder of Cue Biopharma, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnotes (1) and (3). F2 · ownership.nature: The reported shares were purchased, and are owned, directly by Bios Special Opportunity Fund, LP. Aaron Fletcher is the manager of Bios Advisors GP, LLC, the general partner of Bios Capital Management, L.P., the general partner of Bios Equity SOF I, LP, the general partner of Bios Special Opportunity Fund, LP. Dr. Fletcher disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that Dr. Fletcher is the beneficial owner of any securities covered by this Form 4. Read SEC document |
| May 23, 2022 Filed May 25, 2022 13:09 UTC |
Fletcher Aaron G.L.Director
|
PurchaseCommon Stock | 150,000 | $3.52 | $528,000.00 |
DisclosureSEC source: 0001209191-22-031791 · doc4.xml · nonDerivative · entry 1 Fletcher Aaron G.L. · CIK 0001789490 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 885,000 F1 · shares: The reported shares were purchased in the open market in multiple transactions at prices ranging from $3.31 to $3.62. The price reported in Column 4 is a weighted average price. F2 · ownership.nature: The reported shares were purchased, and are owned, directly by Bios Special Opportunity Fund, LP. Aaron Fletcher is the manager of Bios Advisors GP, LLC, the general partner of Bios Capital Management, L.P., the general partner of Bios Equity SOF I, LP, the general partner of Bios Special Opportunity Fund, LP. Dr. Fletcher disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that Dr. Fletcher is the beneficial owner of any securities covered by this Form 4. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 17:29 UTC |
PASSERI DANIEL RDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-022570 · doc4.xml · derivative · entry 4 PASSERI DANIEL R · CIK 0001190121 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 75,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit award represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: One half of the Restricted Stock Units vested on September 30, 2021 and the balance vested on March 31, 2022. F3 · derivative.expiration_date: One half of the Restricted Stock Units vested on September 30, 2021 and the balance vested on March 31, 2022. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 17:29 UTC |
PASSERI DANIEL RDirector · CHIEF EXECUTIVE OFFICER
|
GiftCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-022570 · doc4.xml · nonDerivative · entry 3 PASSERI DANIEL R · CIK 0001190121 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,578 Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 17:29 UTC |
PASSERI DANIEL RDirector · CHIEF EXECUTIVE OFFICER
|
Tax withholdingCommon Stock | 32,122 | $4.88 | $156,755.36 |
DisclosureSEC source: 0001209191-22-022570 · doc4.xml · nonDerivative · entry 2 PASSERI DANIEL R · CIK 0001190121 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,578 Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 17:29 UTC |
PASSERI DANIEL RDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionCommon Stock | 75,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-022570 · doc4.xml · nonDerivative · entry 1 PASSERI DANIEL R · CIK 0001190121 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award. F1 · price: Represents shares of common stock received upon vesting of a restricted stock unit award. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 21:31 UTC |
Suri AnishPRESIDENT AND CSO
|
Exercise / conversionRestricted Stock Units · Derivative | 16,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-022578 · doc4.xml · derivative · entry 3 Suri Anish · CIK 0001739130 · PRESIDENT AND CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,668 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit award represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning on March 31, 2020. F3 · derivative.expiration_date: The restricted stock units vest in three equal annual installments beginning on March 31, 2020. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 21:31 UTC |
Suri AnishPRESIDENT AND CSO
|
Tax withholdingCommon Stock | 7,068 | $4.88 | $34,491.84 |
DisclosureSEC source: 0001209191-22-022578 · doc4.xml · nonDerivative · entry 2 Suri Anish · CIK 0001739130 · PRESIDENT AND CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,638 Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 21:31 UTC |
Suri AnishPRESIDENT AND CSO
|
Exercise / conversionCommon Stock | 16,668 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-022578 · doc4.xml · nonDerivative · entry 1 Suri Anish · CIK 0001739130 · PRESIDENT AND CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,706 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award F1 · price: Represents shares of common stock received upon vesting of a restricted stock unit award Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 21:28 UTC |
Fletcher Aaron G.L.Director
|
PurchaseCommon Stock | 735,000 | $4.76 | $3,498,600.00 |
DisclosureSEC source: 0001209191-22-022568 · doc4.xml · nonDerivative · entry 1 Fletcher Aaron G.L. · CIK 0001789490 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 735,000 F1 · ownership.nature: The reported shares were purchased, and are owned, directly by Bios Special Opportunity Fund, LP. Aaron Fletcher is the manager of Bios Advisors GP, LLC, the general partner of Bios Capital Management, L.P., the general partner of Bios Equity SOF I, LP, the general partner of Bios Special Opportunity Fund, LP. Read SEC document |
| March 25, 2022 Filed Mar 29, 2022 20:13 UTC |
Sandercock ColinSVP, GENERAL COUNSEL
|
GrantStock Option (right to buy) · Derivative | 16,667 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001209191-22-021456 · doc4.xml · derivative · entry 2 Sandercock Colin · CIK 0001724870 · SVP, GENERAL COUNSEL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,667 Underlying: Common Stock · 16,667 shares Expires 2032-03-24 F2 · derivative.exercise_date: 2. This stock option grant becomes exercisable in eight equal semi-annual installments beginning September 25, 2022. Read SEC document |
| March 25, 2022 Filed Mar 29, 2022 16:08 UTC |
PASSERI DANIEL RDirector · CHIEF EXECUTIVE OFFICER
|
GrantStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001209191-22-021449 · doc4.xml · derivative · entry 1 PASSERI DANIEL R · CIK 0001190121 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2032-03-24 F1 · derivative.exercise_date: 1. This stock option grant becomes exercisable in eight equal semi-annual installments beginning September 25, 2022. Read SEC document |
| March 25, 2022 Filed Mar 29, 2022 17:22 UTC |
NASSHORN PATRICIAChief Business Officer
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001209191-22-021502 · doc4.xml · derivative · entry 1 NASSHORN PATRICIA · CIK 0001251374 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2032-03-24 F1 · derivative.exercise_date: 1. This stock option grant becomes exercisable in eight equal semi-annual installments beginning September 25, 2022. Read SEC document |
| March 25, 2022 Filed Mar 29, 2022 16:12 UTC |
Pienta KennethChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001209191-22-021454 · doc4.xml · derivative · entry 1 Pienta Kenneth · CIK 0001571862 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2032-03-24 F1 · derivative.exercise_date: 1. This stock option grant becomes exercisable in eight equal semi-annual installments beginning September 25, 2022. Read SEC document |
| March 25, 2022 Filed Mar 29, 2022 20:15 UTC |
Suri AnishPRESIDENT AND CSO
|
GrantStock Option (right to buy) · Derivative | 21,333 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001209191-22-021458 · doc4.xml · derivative · entry 2 Suri Anish · CIK 0001739130 · PRESIDENT AND CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,333 Underlying: Common Stock · 21,333 shares Expires 2032-03-24 F2 · derivative.exercise_date: 2. This stock option grant becomes exercisable in eight equal semi-annual installments beginning September 25, 2022. F2 · derivative.expiration_date: 2. This stock option grant becomes exercisable in eight equal semi-annual installments beginning September 25, 2022. Read SEC document |
| March 25, 2022 Filed Mar 29, 2022 20:05 UTC |
Millar Kerri-AnnCHIEF FINANCIAL OFFICER
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001209191-22-021446 · doc4.xml · derivative · entry 2 Millar Kerri-Ann · CIK 0001739126 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2032-03-24 F2 · derivative.exercise_date: 2. This stock option grant becomes exercisable in eight equal semi-annual installments beginning September 25, 2022. Read SEC document |
| February 09, 2022 Filed Mar 29, 2022 20:13 UTC |
Sandercock ColinSVP, GENERAL COUNSEL
|
GrantStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $6.91 | $0.00 |
DisclosureSEC source: 0001209191-22-021456 · doc4.xml · derivative · entry 1 Sandercock Colin · CIK 0001724870 · SVP, GENERAL COUNSEL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2032-02-08 F1 · derivative.exercise_date: 1. This stock option grant becomes exercisable in eight equal semi-annual installments beginning August 9, 2022. Read SEC document |
| February 09, 2022 Filed Mar 29, 2022 20:15 UTC |
Suri AnishPRESIDENT AND CSO
|
GrantStock Option (right to buy) · Derivative | 82,000 | $0.00 Strike: $6.91 | $0.00 |
DisclosureSEC source: 0001209191-22-021458 · doc4.xml · derivative · entry 1 Suri Anish · CIK 0001739130 · PRESIDENT AND CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,000 Underlying: Common Stock · 82,000 shares Expires 2032-02-08 F1 · derivative.exercise_date: 1. This stock option grant becomes exercisable in eight equal semi-annual installments beginning August 9, 2022. Read SEC document |
| February 09, 2022 Filed Mar 29, 2022 20:05 UTC |
Millar Kerri-AnnCHIEF FINANCIAL OFFICER
|
GrantStock Option (right to buy) · Derivative | 85,000 | $0.00 Strike: $6.91 | $0.00 |
DisclosureSEC source: 0001209191-22-021446 · doc4.xml · derivative · entry 1 Millar Kerri-Ann · CIK 0001739126 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 85,000 shares Expires 2032-02-08 F1 · derivative.exercise_date: 1. This stock option grant becomes exercisable in eight equal semi-annual installments beginning August 9, 2022. Read SEC document |
| January 03, 2022 Filed Jan 6, 2022 01:22 UTC |
DRISCOLL FREDERICK WDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $12.28 | $0.00 |
DisclosureSEC source: 0000899243-22-001046 · doc4.xml · derivative · entry 1 DRISCOLL FREDERICK W · CIK 0001129890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2032-01-02 F1 · shares: Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy. F2 · derivative.exercise_date: This option was granted on January 3, 2022. The shares underlying the option are scheduled to vest in full on the anniversary of the grant date. Read SEC document |
| January 03, 2022 Filed Jan 6, 2022 01:24 UTC |
HOWSON TAMAR DDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $12.28 | $0.00 |
DisclosureSEC source: 0000899243-22-001050 · doc4.xml · derivative · entry 1 HOWSON TAMAR D · CIK 0001202286 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2032-01-02 F1 · shares: Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy. F2 · derivative.exercise_date: This option was granted on January 3, 2022. The shares underlying the option are scheduled to vest in full on the anniversary of the grant date. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 20:27 UTC |
Kiener Peter ADirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $12.28 | $0.00 |
DisclosureSEC source: 0000899243-22-001052 · doc4.xml · derivative · entry 1 Kiener Peter A · CIK 0001328146 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2032-01-02 F1 · shares: Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy. F2 · derivative.exercise_date: This option was granted on January 3, 2022. The shares underlying the option are scheduled to vest in full on the anniversary of the grant date. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 20:21 UTC |
Gray CameronDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $12.28 | $0.00 |
DisclosureSEC source: 0000899243-22-001045 · doc4.xml · derivative · entry 1 Gray Cameron · CIK 0001590583 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2032-01-02 F1 · shares: Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy. F2 · derivative.exercise_date: This option was granted on January 3, 2022. The shares underlying the option are scheduled to vest in full on the anniversary of the grant date. Read SEC document |
| January 03, 2022 Filed Jan 6, 2022 02:14 UTC |
Fletcher Aaron G.L.Director
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $12.28 | $0.00 |
DisclosureSEC source: 0000899243-22-001069 · doc4.xml · derivative · entry 1 Fletcher Aaron G.L. · CIK 0001789490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2032-01-02 F1 · shares: Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy. F2 · derivative.exercise_date: This option was granted on January 3, 2022. The shares underlying the option are scheduled to vest in full on the anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.